AzTrials
AzTrials

Pain ThresholdNCT06499441

Comparative Effects of Myofascial Induction Therapy Versus Gastrocnemius Pressure Release Treatment on Trigger Point Pressure Pain Threshold in Proximal Muscles and Ankle Range of Motion.

A study testing Myofascial induction in gastrocnemius and Preassure release in people with Pain Threshold and Myofascial Trigger Point, run by Mayuben Private Clinic at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to test the effect of myofascial induction and pre-pressure release of the grastrocnemius muscle on the proximal musculature: biceps femoris, flexor digitorum brevis and extensor digitorum grandus on the pain pre-pressure threshold variable and range of motion of ankle with knee bend and flexed Read more about this study

Who is it for?
Ages 18 to 39 yearsHealthy volunteers can take part
What is being tested?
Myofascial induction in gastrocnemius and Preassure release
Could I receive a placebo?
No, everyone receives an active treatment
How many people
13 participants
Where
1 siteSpain
Study dates
22 Jul 2024to 3 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Subjects from 18 to 39 years old.
  • Healthy subjects with trigger point 1 of the gastrocnemius muscle in both lower limbs

Who cannot join

  • Diagnosis of lower limb injury, including any tendinopathy, bursitis, ligamentous involvement, and/or fasciitis
  • History of lower limb surgery or history of lower-extremity injury with residual symptoms (pain or feeling of sensations) within the last year.
  • Participants could not have undergone ankle stretching or any other treatment.
  • Diabetes due to possible alteration of arterial distal circulation.
  • Foot deformity, cavus, and flat feet.
  • Foot deformities, such as hammer toes and hallux valgus,
  • Plantar corns and calluses.
  • Lower limb dysfunction or chronic injury.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Mayuben Clinic

    San Sebastián de los Reyes, Madrid, 28702

Other trials in Spain

About this study

Official title: Comparative Effects of Myofascial Induction Therapy Versus Gastrocnemius Pressure Release Treatment on Trigger Point Pressure Pain Threshold of the Biceps Femoris, Flexor Digitorum Brevis and Great Extensor Digitorum Muscles and Ankle ROM: Crossover Trial Study.

The aim of the study is to test the effect of myofascial induction and pre-pressure release of the grastrocnemius muscle on the proximal musculature: biceps femoris, flexor digitorum brevis and extensor digitorum grandus on the pain pre-pressure threshold variable and range of motion of ankle with knee bend and flexed

Being tested
Myofascial induction in gastrocnemius, Preassure release
Keywords
Fascia, myofascial trigger point, lower limb

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Myofascial induction in gastrocnemiusOther

    A 3-pass shallow leg gliding technique was applied first, followed by 5 minutes of the deep myofascial calf induction technique described by Pilat.

  • Preassure releaseOther

    Also called ischaemic pressure. Three cycles of pressure are applied to the trigger point of the gastrocnemius muscle until the pain disappears on pressure.

Study groups in NCT06499441
Study groupRoleWhat they receive
Myofascial induction in the gastrocnemius muscleExperimentalA 3-pass shallow leg gliding technique was applied first, followed by 5 minutes of the deep myofascial calf induction technique described by Pilat.
Receives: Other: Myofascial induction in gastrocnemius
Preassure release in gastrocnemius muscleActive comparatorAlso called ischaemic pressure. Three cycles of pressure are applied to the trigger point of the gastrocnemius muscle until the pain disappears on pressure.
Receives: Other: Preassure release

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 1.Threshold of pain on pressure on biceps femoris before.

    The pressure at which the patient starts to feel pain with pressure is measured 3 times with an algometer. It is measured in newtons

    Measured: Immediately before the intervention.

  2. 2.Pain threshold to pressure in the extensor digitorum longus muscle before.

    The pressure at which the patient starts to feel pain with pressure is measured 3 times with an algometer. It is measured in newtons

    Measured: Immediately before the intervention.

  3. 3.Pain threshold to pressure on flexor digitorum brevis muscle before.

    The pressure at which the patient starts to feel pain with pressure is measured 3 times with an algometer. It is measured in newtons

    Measured: Immediately before the intervention.

  4. 4.Pain threshold on biceps femoris pressure after.

    The pressure at which the patient starts to feel pain with pressure is measured 3 times with an algometer. It is measured in newtons

    Measured: Immediately before the intervention.

  5. 5.Pain threshold to pressure in the extensor digitorum longus muscle after.

    The pressure at which the patient starts to feel pain with pressure is measured 3 times with an algometer. It is measured in newtons

    Measured: Immediately before the intervention.

  6. 6.Pain threshold on pressure in the flexor digitorum brevis muscle tras.

    The pressure at which the patient starts to feel pain with pressure is measured 3 times with an algometer. It is measured in newtons

    Measured: Immediately before the intervention.

  7. 7. Ankle range of motion with knee extended before intervention

    The joint amplitude is measured in dorsiflexion of the ankle joint with the knee extended under load and is measured with an inclinometer in degrees.

    measured in degrees.

    Measured: Immediately before the intervention.

  8. 8. Ankle range of motion with knee flexed before intervention

    The joint amplitude is measured in dorsiflexion of the ankle joint with the knee flexed under load and is measured with an inclinometer in degrees.

    measured in degrees.

    Measured: Immediately before the intervention.

  9. 9. Ankle range of motion with knee extended after intervention

    The joint amplitude is measured in dorsiflexion of the ankle joint with the knee extended under load and is measured with an inclinometer in degrees.

    measured in degrees.

    Measured: Immediately after the intervention.

  10. 10. Ankle range of motion with knee flexed after intervention

    The joint amplitude is measured in dorsiflexion of the ankle joint with the knee flexed under load and is measured with an inclinometer in degrees.

    measured in degrees.

    Measured: Immediately after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2024
  2. Study start22 Jul 2024
  3. Primary completion24 Jul 2024
  4. Study completion3 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
13 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06499441
Sponsor's protocol ID
2911202021420C
Status last verified
Aug 2024
First submitted
7 Jul 2024
Last updated
6 Aug 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Myofascial induction in gastrocnemius and Preassure release in people with Pain Threshold and Myofascial Trigger Point, run by Mayuben Private Clinic at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

1.Threshold of pain on pressure on biceps femoris before. (time frame: Immediately before the intervention.). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in